Sanofi

                   

Novartis Earnings Beat Forecasts, Dollar Helps

pharmiweb.co.uk     Jul 17, 2008   65 related          

Novartis, Switzerland, drugmaker, pharmaceuticals, earnings Second-quarter net profit at Novartis rose 17 percent to $2.27 billion, helped by the weak U.S. dollar and cost cutting efforts, beating forecasts and boosting its...                    

comments

Sanofi-Aventis, Johns Hopkins University to jointly research respiratory disease

finanznachrichten.de     Jul 17, 2008   4 related          

PARIS (Thomson Financial) - Sanofi-Aventis and Johns Hopkins University's school of medicine have signed a three-year collaboration agreement for research into respiratory and immuno-allergic diseases. Sanofi and the school of...                    

comments

                   

Novartis:Timing Of German Generic Plavix Launch Tough To Call

pharmiweb.co.uk     Jul 17, 2008          

said Thursday it was difficult to predict when a generic version of Sanofi AG's (SNY) blood-thinner Plavix can be launched in Germany, after the local regulator suspended an approval that it had given earlier because the French...                    

comments

Biophage Pharma appoints two new members to the Board of Directors

tmcnet.com     Jul 16, 2008   2 related          

Attention Business/Financial Editors MONTREAL, July 16 /CNW Telbec/ - (TSX.V: BUG). Biophage Pharma is pleased to announce the appointment of Mr. Luc Dubois and Mr. Jocelyn R. Pelchat to its Board of Directors. Mr. Dubois is...                    

comments

                   
yahoo.com: milkshake_art_200_20080716162022.jpg yahoo.com

Four at Four: Party Time? (at The Wall Street Journal Online)

yahoo.com     Jul 16, 2008   1 related          

Did the market experience its moment of clarity Tuesday? Greg Fierman of Top Gun Financial Planning declared Tuesday’s action to be “capitulation, baby,” noting the 469 million shares that changed hands in the Financial Sector...                    

comments

                   

Big Pharma as the “Good Guys”: One Reason to Embrace Tropical Disease Research

invivoblog.blogspot.com     Jul 16, 2008   2 related          

Here are words you don’t hear too often at Washington, DC press conferences (ed. note: or anywhere else for that matter): “The pharmaceutical companies are really the good guys.”But that is what Global Network for Neglected...                    

comments

                   

Re: OXB Letter to researchers

iii.co.uk     Jul 15, 2008          

Interesting but hard to undersatand as a layman. It reads to me that there are (probably) no safety concerns (small increase in deaths but not statistically significant), and important survival benefits (so far). So why stop...                    

comments

Re: Crazy to buy now!

iii.co.uk     Jul 15, 2008          

Date posted Subject Recommendations Message Boz50 if you have a product worth 15p, but no body has taken that in to the asking price yet, but it will in the run up to the Sept announcement, does that not make it a buy now, or...                    

comments

Micronics Names Larry Hambleton As Vice President of Sales and Marketing

redorbit.com     Jul 14, 2008   2 related          

Micronics, Inc., a leading developer of rapid, molecular diagnostics for near patient, point of care detection of infectious diseases, today announced that it has named Larry Hambleton as its Vice President of Sales and Marketing.                    

comments

Cardiome Takeover More Likely

istockanalyst.com     Jul 14, 2008   36 related          

Cardiome Pharma Corp. (NDAQ: CRME) shares moved sharply higher today after the company announced positive phase IIb results for its oral Vernakalant drug. The experimental drug reduced the rate of abnormal heart rhythms in...                    

comments